Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label

Meningococcal Meningitis disease: Malacards - Research Articles

Structured Benefit-Risk Assessment of a New Quadrivalent

Full article: Immunogenicity and safety of an investigational

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid

Full article: Immunogenicity and safety of a booster dose of a

Safety, immunogenicity, and immune memory of a novel meningococcal

Full article: Immunogenicity and safety of a booster dose of a

Prevention and Control of Meningococcal Disease

Meningococcal B vaccination coverage among older adolescents in

Updated Recommendations for Use of Meningococcal Conjugate

Immunogenicity and safety of a quadrivalent meningococcal tetanus

Core Concepts - Immunizations in Adults - Basic HIV Primary Care

Immunogenicity and safety of a quadrivalent meningococcal tetanus

Quadrivalent meningococcal tetanus toxoid-conjugate booster

PDF) Safety and Immunogenicity of a Quadrivalent Meningococcal